288 related articles for article (PubMed ID: 34464697)
1. Jolkinolide B inhibits proliferation or migration and promotes apoptosis of MCF-7 or BT-474 breast cancer cells by downregulating the PI3K-Akt pathway.
Wang Y; Shen SY; Liu L; Zhang XD; Liu DY; Liu N; Liu BH; Shen L
J Ethnopharmacol; 2022 Jan; 282():114581. PubMed ID: 34464697
[TBL] [Abstract][Full Text] [Related]
2. Jolkinolide B induces apoptosis in MCF-7 cells through inhibition of the PI3K/Akt/mTOR signaling pathway.
Xu HY; Chen ZW; Hou JC; Du FX; Liu JC
Oncol Rep; 2013 Jan; 29(1):212-8. PubMed ID: 23129237
[TBL] [Abstract][Full Text] [Related]
3. Jolkinolide B from Euphorbia fischeriana Steud induces apoptosis in human leukemic U937 cells through PI3K/Akt and XIAP pathways.
Wang JH; Zhou YJ; Bai X; He P
Mol Cells; 2011 Nov; 32(5):451-7. PubMed ID: 22083305
[TBL] [Abstract][Full Text] [Related]
4. Jolkinolide B attenuates laryngeal cancer cell growth and induces apoptosis via PTEN/PI3K/Akt signaling pathway.
Dong L; Liu F; Liu D; Kang S; Yang X; Wang J
In Vitro Cell Dev Biol Anim; 2021 Sep; 57(8):786-794. PubMed ID: 34697781
[TBL] [Abstract][Full Text] [Related]
5. Jolkinolide B induces apoptosis in MDA-MB-231 cells through inhibition of the PI3K/Akt signaling pathway.
Lin Y; Cui H; Xu H; Yue L; Xu H; Jiang L; Liu J
Oncol Rep; 2012 Jun; 27(6):1976-80. PubMed ID: 22426554
[TBL] [Abstract][Full Text] [Related]
6. Jolkinolide A and Jolkinolide B Inhibit Proliferation of A549 Cells and Activity of Human Umbilical Vein Endothelial Cells.
Shen L; Zhang SQ; Liu L; Sun Y; Wu YX; Xie LP; Liu JC
Med Sci Monit; 2017 Jan; 23():223-237. PubMed ID: 28087861
[TBL] [Abstract][Full Text] [Related]
7. Ethyl gallate suppresses proliferation and invasion in human breast cancer cells via Akt-NF-κB signaling.
Cui H; Yuan J; Du X; Wang M; Yue L; Liu J
Oncol Rep; 2015 Mar; 33(3):1284-90. PubMed ID: 25522911
[TBL] [Abstract][Full Text] [Related]
8. Jolkinolide B from Euphorbia fischeriana Steud induces in human leukemic cells apoptosis via JAK2/STAT3 pathways.
Wang JH; Zhang K; Niu HY; Shu LH; Yue DM; Li D; He P
Int J Clin Pharmacol Ther; 2013 Mar; 51(3):170-8. PubMed ID: 23253949
[TBL] [Abstract][Full Text] [Related]
9. Jatrophone: a cytotoxic macrocylic diterpene targeting PI3K/AKT/NF-κB pathway, inducing apoptosis and autophagy in resistant breast cancer cells.
Shari K; El Gedaily RA; Allam RM; Meselhy KM; Khaleel AE; Abdel-Sattar E
BMC Complement Med Ther; 2023 Aug; 23(1):293. PubMed ID: 37608270
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
11. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway.
Huang KF; Zhang GD; Huang YQ; Diao Y
Int Immunopharmacol; 2012 Feb; 12(2):334-41. PubMed ID: 22182776
[TBL] [Abstract][Full Text] [Related]
12. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro.
Yan W; Ma X; Zhao X; Zhang S
Drug Des Devel Ther; 2018; 12():3961-3972. PubMed ID: 30510404
[TBL] [Abstract][Full Text] [Related]
13. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells.
Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV
Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364
[TBL] [Abstract][Full Text] [Related]
14. DP from Euphorbia fischeriana S. mediated apoptosis in leukemia cells via the PI3k/Akt signaling pathways.
Ma L; Chen Z; Li J; Zhang H; Jia Y; Liu J
J Ethnopharmacol; 2021 Oct; 279():113889. PubMed ID: 33524514
[TBL] [Abstract][Full Text] [Related]
15. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway.
Zhong JT; Yu J; Wang HJ; Shi Y; Zhao TS; He BX; Qiao B; Feng ZW
Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209
[TBL] [Abstract][Full Text] [Related]
16. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.
Rabi T; Huwiler A; Zangemeister-Wittke U
Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.
Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764
[TBL] [Abstract][Full Text] [Related]
18. Euphorbia angustifolia lactone B inhibits A549 proliferation and induces apoptosis.
Xie X; Yang H; Yang W; Jiang T
Pak J Pharm Sci; 2021 Nov; 34(6(Special)):2401-2407. PubMed ID: 35039251
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway.
Li G; Xu D; Sun J; Zhao S; Zheng D
Adv Clin Exp Med; 2020 Nov; 29(11):1337-1345. PubMed ID: 33269821
[TBL] [Abstract][Full Text] [Related]
20. Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway.
Chen JM; Bai JY; Yang KX
IUBMB Life; 2018 Jun; 70(6):491-500. PubMed ID: 29637742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
